-
Kanamycin A,
often referred to
simply as
kanamycin, is an
antibiotic used to
treat severe bacterial infections and tuberculosis. It is not a
first line...
- the 3'-hydroxyl
group of a 4,6-disubstituted aminoglycoside, such as
kanamycin. However, APH(3') has also been
found to
phosphorylate at the 5'-hydroxyl...
-
Health Organization's List of
Essential Medicines. It is
derived from
kanamycin.
Amikacin is most
often used for
treating severe infections with multidrug-resistant...
-
examples of
aminoglycosides include the deoxystreptamine-containing
agents kanamycin, tobramycin, gentamicin, and
neomycin (see below).
Aminoglycosides that...
-
which confers resistance to
certain aminoglycoside antibiotics,
including kanamycin and neomycin. On May 18, 1994, the FDA
completed its
evaluation of the...
- In
molecular biology,
kanamycin nucleotidyltransferase EC 2.7.7.- (KNTase) is an
enzyme which is
involved in
conferring resistance to
aminoglycoside antibiotics...
- the
three second line
injectable TB
drugs (amikacin, capreomycin, and
kanamycin). TDR-TB has been
identified in
three countries; India, Iran, and Italy...
- is an
aminoglycoside antibiotic. It is a
semisynthetic derivative of
kanamycin developed by
Hamao Umezawa and
collaborators for
Meiji Seika. It has been...
-
Bekanamycin (INN;
kanamycin B) is an
aminoglycoside antibiotic.
Morales MA,
Castrillon JL,
Hernandez DA (1993). "Effects of
bekanamycin and dibekacin...
- +
kanamycin-B ⇌ {\displaystyle \rightleftharpoons } CoA + N6'-acetylkanamycin-B Thus, the two
substrates of this
enzyme are acetyl-CoA and
kanamycin B...
